Lactotransferrin reduction as a target mechanism of postnatal intestinal vulnerability in murine preeclampsia models

Key Points

• The research investigates the role of lactotransferrin in the development of intestinal vulnerabilities in offspring exposed to preeclampsia.
• Utilized murine preeclampsia models to assess lactotransferrin expression and its effects.
• Conducted immunohistochemistry to evaluate epithelial Ltf expression at different postnatal stages.
• Induced enteritis to test severity in offspring and assessed the impact of prophylactic lactotransferrin supplementation.
• Preeclampsia (PE) offspring exhibited lower lactotransferrin levels compared to controls.
• PE offspring showed increased severity of enteritis, significantly mitigated by prophylactic LTF supplementation.
• Impaired Ltf expression was observed from postnatal day 7 to 21 in PE offspring.

Abstract